Zhende Medical Co., Ltd. (SHA:603301)
China · Delayed Price · Currency is CNY 82.29
+0.47 (0.57%)
Aug 24, 2026, 3:00 PM CST
Zhende Medical Market Cap
Zhende Medical has a market cap or net worth of 21.7 billion as of August 24, 2026. Its market cap has increased by 235.23% in one year.
Market Cap
21.70B
Enterprise Value
22.20B
Revenue
4.34B
Ranking
n/a
PE Ratio
82.31
Stock Price
82.29
ChartMarket Cap Chart
Since April 12, 2018, Zhende Medical's market cap has increased from 2.85B to 21.70B, an increase of 660.47%. That is a compound annual growth rate of 27.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 21.70B | 15.86% |
| Dec 31, 2025 | 18.73B | 219.86% |
| Dec 31, 2024 | 5.86B | -9.58% |
| Dec 29, 2023 | 6.48B | -35.61% |
| Dec 30, 2022 | 10.06B | -13.02% |
| Dec 31, 2021 | 11.56B | -14.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 40.73B |
| iRay Group | 31.62B |
| Intco Medical Technology | 31.36B |
| Andon Health | 29.65B |
| Imeik Technology Development | 27.84B |
| Jiangsu Hualan New Pharmaceutical Material | 17.49B |
| Winner Medical | 16.90B |
| Shenyang Xingqi Pharmaceutical | 14.20B |